2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow PD-1: new trials by email Literature Review of PD-1 trials Research Report on PD-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy PD-1inhibitor, concurrent chemoradiotherapy - HNSCC, Radiotherapy | Phase 3 | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 324 | 2023-01-01 | 2023-08-08 |
| Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma Toripalimab, salvage surgery - Nasopharyngeal Carcinoma, PD-1 | Phase 3 | Recruiting | Sun Yat-sen University | 218 | 2021-03-03 | 2021-03-04 |
Nasopharyngeal Carcinoma (1) · Recurrence (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (2) · Head and Neck Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Carcinoma, Squamous Cell (1) · Disease Attributes (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pharyngeal Diseases (1)
Chemoradiotherapy (1) · spartalizumab (1) · toripalimab (1)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Sun Yat-sen University (1)
China (2)